title: Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99*.
abstract: The anti-human leukocyte antigen (HLA) class I monoclonal antibody (mAb) TP25.99 has a unique specificity since it recognizes both a conformational and a linear determinant expressed on the beta(2)-mu-associated and beta(2)-mu-free HLA class I heavy chains, respectively. Previously, we reported the identification of a cyclic and a linear peptide that inhibits mAb TP25.99 binding to the beta(2)-mu-associated and beta(2)-mu-free HLA class I heavy chains (S. A. Desai, X. Wang, E. J. Noronha, Q. Zhou, V. Rebmann, H. Grosse-Wilde, F. J. Moy, R. Powers, and S. Ferrone, submitted for publication). The linear X(19) and cyclic LX-8 peptides contain sequence homologous to residues 239-242, 245, and 246 and to residues 194-198, respectively, of HLA class I heavy chain alpha(3) domain. Analysis by two-dimensional transfer nuclear Overhauser effect spectroscopy of the induced solution structures of the linear X(19) and cyclic LX-8 peptides in the presence of mAb TP25.99 showed that the two peptides adopt a similar structural motif despite the lack of sequence homology. The backbone fold is suggestive of a short helical segment followed by a tight turn, reminiscent of the determinant loop region (residues 194-198) on beta(2)-mu-associated HLA class I heavy chains. The structural similarity between the linear X(19) and cyclic LX-8 peptides and the lack of sequence homology suggests that mAb TP25.99 predominantly recognizes a structural motif instead of a consensus sequence.
authors.affiliation: Department of Biological Chemistry, Wyeth Research, Cambridge, Massachusetts 02140, USA.
authors.forename: F J
authors.initials: FJ
authors.lastname: Moy
authors.forename: S A
authors.initials: SA
authors.lastname: Desai
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: E J
authors.initials: EJ
authors.lastname: Noronha
authors.forename: Q
authors.initials: Q
authors.lastname: Zhou
authors.forename: S
authors.initials: S
authors.lastname: Ferrone
authors.forename: R
authors.initials: R
authors.lastname: Powers
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal; D003196:Computer Graphics; D018360:Crystallography, X-Ray; D015395:Histocompatibility Antigens Class I / Q000737:chemistry* / Q000276:immunology*; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D019906:Nuclear Magnetic Resonance, Biomolecular / Q000379:methods; D010455:Peptides / Q000737:chemistry / Q000276:immunology*; D010456:Peptides, Cyclic / Q000737:chemistry / Q000276:immunology*; D011487:Protein Conformation; D017433:Protein Structure, Secondary
chemical_list: D000911:Antibodies, Monoclonal; D015395:Histocompatibility Antigens Class I; D010455:Peptides; D010456:Peptides, Cyclic